APP and Alzheimer disease: However, peripheral inflammation [75], aging [86], or AD pathology [87] could disrupt this barrier integrity, allowing activated macrophages in APP/PS1 mice [31] or infection-induced inflammatory cells [36] to breach the barrier and infiltrate the parenchyma, and exacerbate neuroinflammatory cascades.